CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 280 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,868 | +46.2% | 197 | +97.0% | 0.00% | – |
| Q2 2023 | $13,589 | +30.8% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $10,386 | +17.2% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $8,864 | +10.8% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -20.0% | 100 | -6.5% | 0.00% | – |
| Q2 2022 | $10,000 | -37.5% | 107 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | +14.3% | 107 | +7.0% | 0.00% | – |
| Q4 2021 | $14,000 | +7.7% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | -7.1% | 100 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $14,000 | +180.0% | 100 | +11.1% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 90 | +80.0% | 0.00% | – |
| Q4 2019 | $6,000 | -14.3% | 50 | -28.6% | 0.00% | – |
| Q3 2019 | $7,000 | -30.0% | 70 | -36.4% | 0.00% | -100.0% |
| Q2 2019 | $10,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |